Lupus Treatment Research Study
Researchers at Upstate Medical University are conducting a study in adults with Systemic Lupus Erythematosus (SLE) to see if an investigational medication can reduce tiredness.
Fast Facts
Diagnosed With Lupus
18+ Years Old
Compensation Provided
Conducted in Syracuse, NY
Study Background
Systemic Lupus Erythematosus (SLE) Treatment with N-acetylcysteine (NAC) – SNAC
One of the most common symptoms of lupus is extreme fatigue, or feeling tired all the time. In this 13-month research study, we will evaluate an investigational drug, N-acetylcysteine (NAC), which may improve tiredness in people with SLE.
If you have been diagnosed with SLE, you may be eligible to participate. Patients with uncontrolled disease are welcome to apply to be considered. Eventually, the findings of this study might be useful for treating lupus and improving people’s quality of life.
Study Background
Systemic Lupus Erythematosus (SLE) Treatment with N-acetylcysteine (NAC) – SNAC
One of the most common symptoms of lupus is extreme fatigue, or feeling tired all the time. In this 13-month research study, we will evaluate an investigational drug, N-acetylcysteine (NAC), which may improve tiredness in people with SLE.
If you have been diagnosed with SLE, you may be eligible to participate. Patients with uncontrolled disease are welcome to apply to be considered. Eventually, the findings of this study might be useful for treating lupus and improving people’s quality of life.
Additional Information
The goal of this research study is to evaluate an investigational medication, N-acetylcysteine (NAC), to reduce tiredness in individuals with Systemic Lupus Erythematosus.
You may qualify for a study if you meet the following criteria.
Inclusion Criteria:
- 18+ years old
- Diagnosed with lupus (Systemic Lupus Erythematosus)
- Individuals with uncontrolled disease are welcome to apply to be considered.
- If applicable, on stable immunosuppressants
- No serious comorbidities (e.g., diabetes, heart failure, COPD)
- Have not taken cyclophosphamide in the last 3 months
- If female, not pregnant or breastfeeding
- Have not taken rituximab in the last 12 months or other biologic therapy
- Not taking medications containing acetaminophen (Tylenol)
- Not currently enrolled in another interventional trial
Taking part in the study will last about 13 months. The study involves visits where participants will be given either the study drug or a placebo (a sugar pill). Some visits will involve blood draws and answering questionnaires (a list of questions).
As a participant, you can receive up to $80 per study visit.
There is no cost for you to participate in our research study.
